Approval · Notice of Compliance 6387 · 2005
ZEMPLAR: Notice of Compliance 6387
Issued March 31, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6387
- Date
- March 31, 2005
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Vitamin D analog
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEMPLAR | 02266202 | Cancelled Post Market |
Medicinal ingredients
- PARICALCITOL 5 MCG per ML